reformulated bucillamine (Revive Therapeutics)

N/A

Report date: 2025/06/11 10:21:37
NME

Base Information

Drug Namereformulated bucillamine (Revive Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsReperfusion InjuryRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRevive Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRevive Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsReperfusion InjuryRespiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A